Puylaert Kevin Insider Trading Activity
Puylaert Kevin has been net-selling over the last 12 months with 0 purchases and 7 sales across 1 company.
SOPH is the most-traded position with 7 trades. The largest single transaction was a sale of SOPH for $3K on Apr 6, 2026.
Performance Scorecard
Forward stock performance after each transaction by Puylaert Kevin. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -6.6% | 14% | 7 |
| 90 days | — | -15.3% | 0% | 6 |
| 120 days | — | -23.3% | 0% | 1 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersSOPH · SOPHiA GENETICS SA
🔒 Subscribe to see trade entries
Pro members see exactly when Puylaert Kevin bought and sold SOPH.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 19, 2026 | SOPH | Sell | 33 | $4.54 | $149.899 | −0.0% | Chief Sales Officer | |
Apr 20, 2026 | SOPH | Sell | 33 | $5.08 | $167.693 | −0.0% | Chief Sales Officer | |
Apr 6, 2026 | SOPH | Sell | 548 | $4.86 | $3K | −0.4% | Chief Sales Officer | |
Apr 6, 2026 | SOPH | Sell | 46 | $4.86 | $223.56 | −0.0% | Chief Sales Officer | |
Apr 6, 2026 | SOPH | Sell | 30 | $4.83 | $144.9 | −0.0% | Chief Sales Officer | |
Mar 31, 2026 | SOPH | Sell | 3 | $4.71 | $14.13 | −0.0% | Chief Sales Officer | |
Mar 19, 2026 | SOPH | Sell | 33 | $4.76 | $157.08 | −0.0% | Chief Sales Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| SOPH | SOPHiA GENETICS SA | 7 | $4K |
Other insiders at SOPHiA GENETICS SA
8 other tracked filers at SOPH.